Rhythm Pharmaceuticals Inc (NAS:RYTM)
$ 64.3 -1.28 (-1.95%) Market Cap: 3.95 Bil Enterprise Value: 3.74 Bil PE Ratio: 0 PB Ratio: 357.50 GF Score: 60/100

Rhythm Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 12, 2020 / 12:20PM GMT
Release Date Price: $19.14 (-6.18%)
Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP

Good morning, everyone. Thanks for joining us at our Virtual Bank of America Conference. I am Tazeen Ahmad, one of the biotech analysts here at the firm. It's my pleasure this morning to start off the conference with our first presenting company, Rhythm Pharmaceuticals.

With me this morning are two folks who might know a little bit about the company, Hunter Smith, who is the Interim Chief Executive Officer and Chief Financial Officer; as well as Murray Stewart, Chief Medical Officer. Good morning, gentlemen. Thanks for joining us this morning.

Murray W. Stewart
Rhythm Pharmaceuticals, Inc. - Chief Medical Officer

Thank you.

Hunter C. Smith
Rhythm Pharmaceuticals, Inc. - CFO, Treasurer, Secretary, Interim President & CEO

Good morning, Tazeen. Thanks so much for hosting us.

Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP

Of course. So as we kick off our virtual conference, a lot of times, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot